Quantcast

Zecotek to Develop 3D Printer

February 27, 2014

SINGAPORE, Feb. 27, 2014 /PRNewswire/ – Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F), a developer of leading-edge photonics technologies for medical,
industrial and scientific markets, today announced that its wholly
owned subsidiary Zecotek Display Systems Pte. Ltd. is designing a
unique 3D printer which will offer technical and commercial competitive
advantages to existing 3D printers. Zecotek is working with LT-Pyrkal
of Yerevan, Armenia, a long time contract partner which developed a
number of key elements for Zecotek`s own patented 3D display
technology. This is Zecotek`s second product offering to the 3D market
following the recently announced 3D printing platform which offers
significant design, cost, and time advantages when Zecotek’s glasses
free, auto-stereoscopic, multi-view, HD 3D display.

“By combining our vast experience in laser technology and high precision
electro-mechanical devices Zecotek and LT-Pyrkal are exploring novel
designs for a compact and high speed 3D printer,” said Dr. A.F.
Zerrouk, Chairman, President, and CEO of Zecotek Photonics Inc. “Our
technical expertise has allowed our partnership to explore new and more
efficient methods of printing 3 dimensional objects with a large
spectrum of materials. We are testing components of a compact, high
speed 3D printer to be used in rapid prototyping and rapid
manufacturing, as well as the associated software interface and look
forward to working with LT-Pyrkal to move this project forward.”

3D printing is the process of making three dimensional solid objects from a digital model by laying down successive layers of material in different shapes.
Companies are using 3D printing to evaluate more product models in less
time to improve design throughout the product development process. As
the design of a product advances, technical issues are tested at
various points to achieve improved performance, lower manufacturing
costs, while delivering higher quality and more successful product
launches. In rapid prototyping, 3D printing is enables faster more
efficient production that supports marketing and sales. Rapid
manufacturing enables higher productivity, economical customization,
improved quality and greater efficiency in a growing number of
industries.

Total annual sales and service of 3D printers has reached $2 billion.
Leading industry analysts predict continued significant growth with
annual sales of 3D printing reaching $4 billion by 2015, and over $10
billion by 2021. The rapid growth in the market is due to the
improving performance of additive equipment and the expanding range of
materials being used. Although 3D printing has now become cheaper and
more customizable than regular manufacturing methods, there are a
number of opportunities for improvement. Zecotek and LT-Pyrkal new 3D
printer will be used for both prototyping and distributed manufacturing with applications in many industries including dental, medical,
biotech, architecture, industrial design, aerospace, military, civil engineering, and geographic information systems.

About LT-Pyrkal

LT-PYRKAL is a Greek-Armenian research, development and production
company, specializing in crystal growth, laser accessories and
components, lasers and systems. LT-PYRKAL was established in 1999 and
todays employs over 250 highly qualified specialists and occupies over
30.000 square meters of industrial facilities for for synthetic crystal
growth, opto-mechanics and laser electronics manufacturing, and laser
and EO Systems development. For more information please visit: http://www.lt-pyrkal.com/en/.

About Zecotek

Zecotek Photonics Inc (TSX-V: ZMS; Frankfurt: W1I) is a photonics
technology company developing high-performance scintillation crystals,
photo detectors, positron emission tomography scanning technologies, 3D
auto-stereoscopic displays, and lasers for applications in medical,
high-tech and industrial sectors. Founded in 2004, Zecotek operates
three divisions: Imaging Systems, Laser Systems and 3D Display Systems
with labs located in Canada, Korea, Russia, Singapore and U.S.A. The
management team is focused on building shareholder value by
commercializing over 50 patented and patent pending novel photonic
technologies directly and through strategic alliances and joint
ventures with leading industry partners such as the European
Organization for Nuclear Research (Switzerland), Beijing
Opto-Electronics Technology Co. Ltd. (China), NuCare Medical Systems
(South Korea), and National NanoFab Center (South Korea). For more
information visit www.zecotek.com, follow @zecotek on Twitter and “like” us in Facebook at www.facebook.com/zecotek.

This press release may contain forward-looking statements that are based
on management’s expectations, estimates, projections and assumptions.
These statements are not guarantees of future performance and involve
certain risks and uncertainties, which are difficult to predict.
Therefore, actual future results and trends may differ materially from
what may have been stated.

The TSX Venture 50® are the top 10 companies listed on the TSX Venture
Exchange, in each of five major industry sectors – mining, oil & gas,
technology & life sciences, diversified industries and clean technology
– based on a ranking formula with equal weighting given to return on
investment, market cap growth, trading volume and analyst coverage. All
data was as of December 31, 2013.

Neither the TSX Venture Exchange nor its Regulation Service Provider (as
that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of the content of
this news release. If you would like to receive news from Zecotek in
the future please visit the corporate website at www.zecotek.com.

SOURCE Zecotek Photonics Inc.


Source: PR Newswire



comments powered by Disqus